Cervical carcinoma cells stimulate the angiogenesis through TSLP promoting growth and activation of vascular endothelial cells

American Journal of Reproductive Immunology

Volumn 70, Issue 1, 2013, Pages 69-79

  Xie, Feng ^a   Meng, Yu Han ^a   Liu, Li Bing ^a,b   Chang, Kai Kai ^a   Li, Hui ^a   Li, Ming Qing ^a   Li, Da Jin ^a  

^a FUDAN UNIVERSITY   (China)

^b Soochow University   (China)

Author keywords

Angiogenesis; Cervical carcinoma cells; Proliferation; TSLP; Vascular endothelial cells

Indexed keywords

INTERLEUKIN 6; NEUTRALIZING ANTIBODY; THYMIC STROMAL LYMPHOPOIETIN;

ADULT; ANGIOGENESIS; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL ACTIVATION; CELL PROLIFERATION; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; UTERINE CERVIX CARCINOMA;

ADULT; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; CYTOKINES; ENDOTHELIAL CELLS; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-6; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CYTOKINE; UTERINE CERVICAL NEOPLASMS;

EID: 84879021056     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12104     Document Type: Article

References (43)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-2917.
2. Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, Ferlay J: Worldwide burden of cervical cancer in 2008. Ann Oncol 2011; 22:2675-2686.
3. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992; 267:10931-10934.
4. Breier G: Angiogenesis in embryonic development - A review. Placenta 2000; 21:S11-S15.
5. Iruela-Arispe ML, Dvorak HF: Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb Haemost 1997; 78:672-677.
6. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001; 7:1194-1201.
7. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6:389-395.
8. Fujimoto J, Sakaguchi H, Aoki I, Tamaya T: Clinical implications of expression of interleukin-8 related to angiogenesis in uterine cervical cancers. Cancer Res 2000; 60:2632-2635.
9. Lopez-Ocejo O, Viloria-Petit A, Bequet-Romero M, Mukhopadhyay D, Rak J, Kerbel RS: Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. Oncogene 2000; 19:4611-4620.
10. Toussaint-Smith E, Donner DB, Roman A: Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors. Oncogene 2004; 23:2988-2995.
11. Hammes LS, Tekmal RR, Naud P, Edelweiss MI, Kirma N, Valente PT, Syrjänen KJ, Cunha-Filho JS: Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease. Gynecol Oncol 2008; 110:445-451.
12. Chen RJ, Chen SU, Chou CH, Lin MC: Lysophosphatidic acid receptor 2/3-mediated IL-8-dependent angiogenesis in cervical cancer cells. Int J Cancer 2012; 131:789-802.
13. Letamendia A, Lastres P, Botella LM, Raab U, Langa C, Velasco B, Attisano L, Bernabeau C: Role of endoglin in cellular responses to transforming growth factor beta-A comparative study with betaglycan. J Biol Chem 1998; 273:33011-33019.
14. Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M: Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 2003; 22:6557-6563.
15. Haviv YS, Curiel DT: Conditional gene targeting for cancer gene therapy. Adv Drug Deliv Rev 2001; 53:135-154.
16. Kraling BM, Razon MJ, Boon LM, Zurakowski D, Seachord C, Darveau RP, Mulliken JB, Corless CL, Bischoff J: E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Pathol 1996; 148:1181-1191.
17. Seguin J, Nicolazzi C, Mignet N, Scherman D, Chabot GG: Vascular density and endothelial cell expression of integrin alpha v beta 3 and E-selectin in murine tumours. Tumor Biol 2012; 33:1709-1717.
18. Liu YJ. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J Allergy Clin Immunol 2007; 120:238-244; quiz 245-246.
19. Liu YJ, Soumelis V, Watanabe N, Ito T, Wang YH, Malefyt Rde W, Omori M, Zhou B, Ziegler SF: An epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 2007; 25:193-219.
20. Lin Y, Zhong Y, Shen W, Chen Y, Shi J, Di J, Zeng S, Saito S: TSLP-induced placenta DC activation and IL-10(+) NK cell expansion: comparative study based on BALB/cxC57BL/6 and NOD/SCIDxC57BL/6 preganant models. Clin Immunol 2008; 126:104-117.
21. Lin Y, Wang W, Jin H, Zhong Y, Di J, Zeng S, Saito S: Comparison of murine thymic stromal lymphopoietin- and polyinosinic polycytidylic acid-mediated placental dendritic cell activation. Clin Immunol 2009; 79:119-128.
22. Guo PF, Du MR, Wu HX, Lin Y, Jin LP, Li DJ: Thymic stromal lymphopoietin from trophoblasts induces dendritic cell-mediated regulatory TH2 bias in the decidua during early gestation in humans. Blood 2010; 116:2061-2069.
23. Olkhanud PB, Rochman Y, Bodogai M, Malchinkhuu E, Wejksza K, Xu M, Gress RE, Hesdorffer C, Leonard WJ, Biragyn A: Thymic stromal lymphopoietin is a key mediator of breast cancer progression. J Immunol 2011; 186:5656-5662.
24. Wu HX, Guo PF, Jin LP, Liang SS, Li DJ: Functional regulation of thymic stromal lymphopoietin on proliferation and invasion of trophoblasts in human first-trimester pregnancy. Hum Reprod 2010; 25:1146-1152.
25. Wang Y, Fan DX, Duan J, Li MQ, Zhu XY, Jin LP: Thymic stromal lymphopoietin downregulates NME1 expression and promotes invasion in human trophoblasts via the activation of STAT3 signaling pathway. Clin Immunol 2012; 143:88-95.
26. Shan LY, Redhu NS, Saleh A, Halayko AJ, Chakir J, Gounni AS: Thymic stromal lymphopoietin receptor-mediated IL-6 and CC/CXC chemokines expression in human airway smooth muscle cells: role of MAPKs (ERK1/2, p38, and JNK) and STAT3 pathways. J Immunol 2010; 184:7134-7143.
27. Klein D, Demory A, Peyre F, Kroll J, Augustin HG, Helfrich W, Kzhyshkowska J, Schledzewski K, Arnold B, Goerdt S: Wnt2 acts as a cell type-specific, autocrine growth factor in rat hepatic sinusoidal endothelial cells cross-stimulating the VEGF pathway. Hepatology 2008; 47:1018-1031.
28. Scholzen T, Gerdes J: The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182:311-322.
29. Friend SL, Hosier S, Nelson A, Foxworthe D, Williams DE, Farr A: A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol 1994; 22:321-328.
30. Sims JE, Williams DE, Morrissey PJ, Garka K, Foxworthe D, Price V, Friend SL, Farr A, Bedell MA, Jenkins NA, Copeland NG, Grabstein K, Paxton RJ: Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J Exp Med 2000; 192:671-680.
31. Reche PA, Soumelis V, Gorman DM, Clifford T, Liu MR, Travis M, Zurawski SM, Johnston J, Liu YJ, Spits H, de Waal Malefyt R, Kastelein RA, Bazan JF: Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol 2001; 167:336-343.
32. Quentmeier H, Drexler HG, Fleckenstein D, Zaborski M, Armstrong A, Sims JE, Lyman SD: Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation. Leukemia 2001; 15:1286-1292.
33. Liu YJ: Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006; 203:269-273.
34. Saenz SA, Taylor BC, Artis D: Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev 2008; 226:172-190.
35. Ziegler SF: The role of thymic stromal lymphopoietin (TSLP) in allergic disorders. Curr Opin Immunol 2010; 22:795-799.
36. Ziegler SF, Artis D: Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 2010; 11:289-293.
37. De Monte L, Reni M, Tassi E, Clavenna D, Papa I, Recalde H, Braga M, Di Carlo V, Doglioni C, Protti MP: Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med 2011; 208:469-478.
38. Pedroza-Gonzalez A, Xu K, Wu TC, Aspord C, Tindle S, Marches F, Gallegos M, Burton EC, Savino D, Hori T, Tanaka Y, Zurawski S, Zurawski G, Bover L, Liu YJ, Banchereau J, Palucka AK: Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J Exp Med 2011; 208:479-490.
39. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW: Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004; 10:6897-6904.
40. Barbara NP, Wrana JL, Letarte M: Endoglin is an accessory protein that interact with the signaling receptor complex of multiple members of the transforming growth factor-h superfamily. J Biol Chem 1999; 274:584-594.
41. Wang JM, Kumar S, Pye D, van Agthoven AJ, Krupinski J, Hunter RD: A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int J Cancer 1993; 54:363-370.
42. Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB, Wendel DP: Defective angiogenesis in mice lacking endoglin. Science 1999; 284:1534-1537.
43. Tabatabai G, Herrmann C, von Kürthy G, Mittelbronn M, Grau S, Frank B, Möhle R, Weller M, Wick W: VEGF-dependent induction of CD62E on endothelial cells mediates glioma tropism of adult haematopoietic progenitor cells. Brain 2008; 131:2579-2595.